Markets:

Overview

News

Currencies

International

Treasuries

RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

57.57 +22.47 (+64.02%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about RAPT Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 24, 2022

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million.

Via Benzinga

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗

August 12, 2022

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.

Via Benzinga

Expert Ratings For RAPT Therapeutics ↗

August 12, 2022

RAPT Therapeutics (NASDAQ:RAPT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Recap: RAPT Therapeutics Q2 Earnings ↗

August 11, 2022

RAPT Therapeutics (NASDAQ:RAPT) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

This Mid-Cap Firm Can Potentially Offer Biggest Oral Drug In Atopic Dermatitis, Cantor Thinks So ↗

May 25, 2022

Via Benzinga

Recap: RAPT Therapeutics Q1 Earnings ↗

May 11, 2022

RAPT Therapeutics (NASDAQ:RAPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for RAPT Therapeutics: Here's What You Need To Know ↗

August 12, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of RAPT Therapeutics (NASDAQ:RAPT) and raise its price target from $50.00 to $53.00. Shares of RAPT Therapeutics are trading up 14.98% over...

Via Benzinga

LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday ↗

August 12, 2022

WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests...

Via Benzinga

What 4 Analyst Ratings Have To Say About RAPT Therapeutics ↗

May 24, 2022

Analysts have provided the following ratings for RAPT Therapeutics (NASDAQ:RAPT) within the last quarter:

Via Benzinga

Starbucks And 2 Other Stocks Insiders Are Buying ↗

May 13, 2022

Although the Dow Jones jumped by more than 400 points on Friday, there were a few notable insider trades.

Via Benzinga

RAPT Therapeutics's Return On Capital Employed Insights ↗

March 14, 2022

According to Benzinga Pro data, during Q4, RAPT Therapeutics (NASDAQ:RAPT) posted sales of $756.00 thousand. Earnings were up 3.87%, but RAPT Therapeutics still reported an...

Via Benzinga

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗

July 29, 2022

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

RAPT Therapeutics: Q4 Earnings Insights ↗

March 10, 2022

RAPT Therapeutics (NASDAQ:RAPT) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 19, 2022

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and...

Via Benzinga

60 Biggest Movers From Yesterday ↗

January 11, 2022

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company...

Via Benzinga

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021 ↗

December 09, 2021

Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:

Via Benzinga

How Good Are RAPT Therapeutics's Earnings? | Return On Capital Employed ↗

September 28, 2021

According to Benzinga Pro data, during Q2, RAPT Therapeutics (NASDAQ:RAPT) posted sales of $869.00 thousand. Earnings were up 2.9%, but RAPT Therapeutics still reported an overall...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗

September 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021 ↗

August 12, 2021

Upgrades According to Northland Capital Markets, the prior rating for Points International Ltd

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

June 23, 2021

Wedbush boosted Microsoft Corporation (NASDAQ: MSFT) price target from $310 to $325. Microsoft shares slipped 0.1% to $265.48 in pre-market trading. Morgan Stanley boosted...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021 ↗

June 21, 2021

Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 21, 2021

Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5...

Via Benzinga

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 16, 2021

Gainers Kindred Biosciences (NASDAQ:KIN) shares moved upwards by 45.26% to $9.21 during Wednesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

RAPT Therapeutics Raises $125M Via Equity At 6% Discount ↗

June 16, 2021

RAPT Therapeutics Inc (NASDAQ: RAPT) has priced its previously announced underwritten public offering of 3.8 million shares at $33/share. The price represents a 6...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 15, 2021

Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs. Significant Points: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.